Literature DB >> 19175705

Serum and tissue expression of transforming growth factor beta 1 in psoriasis.

H Zaher1, O G Shaker, M H M EL-Komy, A El-Tawdi, M Fawzi, D Kadry.   

Abstract

BACKGROUND: In psoriasis, keratinocyte hyperplasia may be explained by imbalance of growth factors responsible for epidermal proliferation and altered metabolism of their receptors. Transforming growth factor-beta 1 (TGF-beta1) implications in the pathogenesis of psoriasis can be attributed to several mechanisms besides keratinocyte cell cycle inhibition.
OBJECTIVES: To evaluate the relation between serum and tissue levels of TGF-beta1 in psoriasis and their correlation with disease parameters. PATIENTS AND METHODS: Serum and punch biopsy of involved and non-involved skin of 22 patients with psoriasis vulgaris and 10 controls were collected for quantification of TGF-beta1 by enzyme-linked immunosorbent assay kit.
RESULTS: Serum level of TGF-beta1 in psoriatic patients was higher than controls in a statistically non-significant manner. Correlations between serum level of TGF-beta1 and extent of the disease (P = 0.007) and Psoriasis Area and Severity Index (PASI) score (P = 0.005) were observed. Mean tissue levels of TGF-beta1 were highest in psoriatic lesions in contrast to normal skin of psoriatic patients and healthy controls, but not statistically significant. Correlation between tissue levels of TGF-beta1 in non-involved skin and extent of the disease (P = 0.007) and PASI score (P = 0.013) was detected. Correlation was detected between levels of TGF-beta1 in psoriatic plaques and serum of patients (P = 0.035), but not between levels of TGF-beta1 in non-involved skin and serum.
CONCLUSIONS: Tissue expression of TGF-beta1 in psoriasis may be affected by the stage of development of the lesion. The direct relation between TGF-beta1 in psoriatic plaques and serum imply that the mechanisms for TGF-beta1 production and release in both these compartments may be related.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19175705     DOI: 10.1111/j.1468-3083.2008.03064.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  12 in total

1.  TGF-beta 1 is a potential regulator of vaginal tropoelastin production.

Authors:  Peter Takacs; Yanping Zhang; Sujata Yavagal; Keith Candiotti; Nahida Chakhtoura; Carlos A Medina
Journal:  Int Urogynecol J       Date:  2011-11-09       Impact factor: 2.894

2.  Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity.

Authors:  Abdel-Raheim M A Meki; Hani Al-Shobaili
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

3.  Proinflammatory and anti-inflammatory cytokine profiles in psoriasis: use as laboratory biomarkers and disease predictors.

Authors:  Camila Cataldi; Naiara Lourenço Mari; Marcell Alysson Batisti Lozovoy; Ligia Márcia Mário Martins; Edna Maria Vissoci Reiche; Michael Maes; Isaias Dichi; Andréa Name Colado Simão
Journal:  Inflamm Res       Date:  2019-05-06       Impact factor: 4.575

4.  Expression of B lymphocyte-induced maturation protein 1 (Blimp-1) in keratinocyte and cytokine signalling drives human Th17 response in psoriasis.

Authors:  Lorena Carla Oliveira da Costa; Luiz Gustavo Gardinassi; Flávio Protásio Veras; Cristiane Milanezi; Leandra Náira Zambelli Ramalho; Luciana Benevides; José Carlos Alves-Filho; João Santana da Silva; Cacilda da Silva Souza
Journal:  Arch Dermatol Res       Date:  2022-08-30       Impact factor: 3.033

5.  The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients - preliminary report.

Authors:  Agnieszka Owczarczyk-Saczonek; Marek Drozdowski; Agata Maciejewska-Radomska; Dariusz Choszcz; Waldemar Placek
Journal:  Postepy Dermatol Alergol       Date:  2018-02-20       Impact factor: 1.837

Review 6.  Saliva as a Future Field in Psoriasis Research.

Authors:  Farah Asa'ad; Marco Fiore; Aniello Alfieri; Paolo Daniele Maria Pigatto; Chiara Franchi; Emilio Berti; Carlo Maiorana; Giovanni Damiani
Journal:  Biomed Res Int       Date:  2018-05-20       Impact factor: 3.411

7.  Evaluation of selected mechanisms of immune tolerance in psoriasis.

Authors:  Agnieszka Owczarczyk-Saczonek; Joanna Czerwińska; Małgorzata Orylska; Waldemar Placek
Journal:  Postepy Dermatol Alergol       Date:  2019-06-19       Impact factor: 1.837

8.  Dermal Extracellular Matrix-Derived Hydrogels as an In Vitro Substrate to Study Mast Cell Maturation.

Authors:  Emily W Ozpinar; Ariana L Frey; Greer K Arthur; Camilo Mora-Navarro; Andreea Biehl; Douglas B Snider; Glenn Cruse; Donald O Freytes
Journal:  Tissue Eng Part A       Date:  2020-11-19       Impact factor: 4.080

Review 9.  The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease.

Authors:  Mircea Tampa; Maria-Isabela Sarbu; Madalina-Irina Mitran; Cristina-Iulia Mitran; Clara Matei; Simona-Roxana Georgescu
Journal:  Dis Markers       Date:  2018-01-28       Impact factor: 3.434

Review 10.  Stem Cells as Potential Candidates for Psoriasis Cell-Replacement Therapy.

Authors:  Agnieszka Owczarczyk-Saczonek; Magdalena Krajewska-Włodarczyk; Anna Kruszewska; Waldemar Placek; Wojciech Maksymowicz; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.